Amiodarone vs sotalol as prophylaxis against atrial fibrillation/flutter after heart surgery: A Meta-analysis

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Background: The incidence of supraventricular arrhythmias remains high following open-heart surgery. The most common of these arrhythmias are atrial fibrillation and flutter (AFF), for which treatment is not well defined. Recent studies have focused on prophylactically treating patients in an attempt to reduce postoperative AFF. Several studies have shown that sotalol and amiodarone are both effective in reducing AFF following heart surgery. However, no studies have been done comparing both drugs. Methods: A meta-analysis was done to compare the efficacy of sotalol and amiodarone after bypass graft surgery. Randomized controlled trials were included if patients were clearly monitored, and the incidence of AFF was noted. Ten studies were included in the final analysis. Results: Both amiodarone and sotalol were more effective than placebo treatment in reducing the incidence of postoperative AFF. However, when the data were pooled, no differences were noted between amiodarone and sotalol for efficacy (sotalol, - 21.5%; 95% confidence interval [CI], - 28.3 to - 14.6; amiodarone, - 14.1%; CI, - 20.1 to - 8.1), length of stay (sotalol, - 0.13 d; CI, - 0.33 to 0.07 d; amiodarone, - 0.18; CI, - 0.38 to 0.02 d), or adverse drug reactions causing drug termination (sotalol, 9.7%; CI, 0.086 to 19.3; amiodarone, 1.95%; CI, - 0.48 to 4.38). Conclusions: This data would suggest that either drug could be used in a prophylactic regimen to reduce the incidence of AFF following heart surgery.

Original languageEnglish
Pages (from-to)1203-1210
Number of pages8
JournalChest
Volume121
Issue number4
DOIs
StatePublished - 2002

Fingerprint

Sotalol
Atrial Flutter
Amiodarone
Atrial Fibrillation
Thoracic Surgery
Meta-Analysis
Confidence Intervals
Incidence
Cardiac Arrhythmias
Pharmaceutical Preparations
Drug-Related Side Effects and Adverse Reactions
Length of Stay
Randomized Controlled Trials
Placebos
Transplants
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pulmonary and Respiratory Medicine

Cite this

Amiodarone vs sotalol as prophylaxis against atrial fibrillation/flutter after heart surgery : A Meta-analysis. / Wurdeman, Richard L.; Mooss, Aryan N.; Mohiuddin, Syed M.; Lenz, Thomas L.

In: Chest, Vol. 121, No. 4, 2002, p. 1203-1210.

Research output: Contribution to journalArticle

@article{8e2ee9d18a0345c387d116db510c2309,
title = "Amiodarone vs sotalol as prophylaxis against atrial fibrillation/flutter after heart surgery: A Meta-analysis",
abstract = "Background: The incidence of supraventricular arrhythmias remains high following open-heart surgery. The most common of these arrhythmias are atrial fibrillation and flutter (AFF), for which treatment is not well defined. Recent studies have focused on prophylactically treating patients in an attempt to reduce postoperative AFF. Several studies have shown that sotalol and amiodarone are both effective in reducing AFF following heart surgery. However, no studies have been done comparing both drugs. Methods: A meta-analysis was done to compare the efficacy of sotalol and amiodarone after bypass graft surgery. Randomized controlled trials were included if patients were clearly monitored, and the incidence of AFF was noted. Ten studies were included in the final analysis. Results: Both amiodarone and sotalol were more effective than placebo treatment in reducing the incidence of postoperative AFF. However, when the data were pooled, no differences were noted between amiodarone and sotalol for efficacy (sotalol, - 21.5{\%}; 95{\%} confidence interval [CI], - 28.3 to - 14.6; amiodarone, - 14.1{\%}; CI, - 20.1 to - 8.1), length of stay (sotalol, - 0.13 d; CI, - 0.33 to 0.07 d; amiodarone, - 0.18; CI, - 0.38 to 0.02 d), or adverse drug reactions causing drug termination (sotalol, 9.7{\%}; CI, 0.086 to 19.3; amiodarone, 1.95{\%}; CI, - 0.48 to 4.38). Conclusions: This data would suggest that either drug could be used in a prophylactic regimen to reduce the incidence of AFF following heart surgery.",
author = "Wurdeman, {Richard L.} and Mooss, {Aryan N.} and Mohiuddin, {Syed M.} and Lenz, {Thomas L.}",
year = "2002",
doi = "10.1378/chest.121.4.1203",
language = "English",
volume = "121",
pages = "1203--1210",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "4",

}

TY - JOUR

T1 - Amiodarone vs sotalol as prophylaxis against atrial fibrillation/flutter after heart surgery

T2 - A Meta-analysis

AU - Wurdeman, Richard L.

AU - Mooss, Aryan N.

AU - Mohiuddin, Syed M.

AU - Lenz, Thomas L.

PY - 2002

Y1 - 2002

N2 - Background: The incidence of supraventricular arrhythmias remains high following open-heart surgery. The most common of these arrhythmias are atrial fibrillation and flutter (AFF), for which treatment is not well defined. Recent studies have focused on prophylactically treating patients in an attempt to reduce postoperative AFF. Several studies have shown that sotalol and amiodarone are both effective in reducing AFF following heart surgery. However, no studies have been done comparing both drugs. Methods: A meta-analysis was done to compare the efficacy of sotalol and amiodarone after bypass graft surgery. Randomized controlled trials were included if patients were clearly monitored, and the incidence of AFF was noted. Ten studies were included in the final analysis. Results: Both amiodarone and sotalol were more effective than placebo treatment in reducing the incidence of postoperative AFF. However, when the data were pooled, no differences were noted between amiodarone and sotalol for efficacy (sotalol, - 21.5%; 95% confidence interval [CI], - 28.3 to - 14.6; amiodarone, - 14.1%; CI, - 20.1 to - 8.1), length of stay (sotalol, - 0.13 d; CI, - 0.33 to 0.07 d; amiodarone, - 0.18; CI, - 0.38 to 0.02 d), or adverse drug reactions causing drug termination (sotalol, 9.7%; CI, 0.086 to 19.3; amiodarone, 1.95%; CI, - 0.48 to 4.38). Conclusions: This data would suggest that either drug could be used in a prophylactic regimen to reduce the incidence of AFF following heart surgery.

AB - Background: The incidence of supraventricular arrhythmias remains high following open-heart surgery. The most common of these arrhythmias are atrial fibrillation and flutter (AFF), for which treatment is not well defined. Recent studies have focused on prophylactically treating patients in an attempt to reduce postoperative AFF. Several studies have shown that sotalol and amiodarone are both effective in reducing AFF following heart surgery. However, no studies have been done comparing both drugs. Methods: A meta-analysis was done to compare the efficacy of sotalol and amiodarone after bypass graft surgery. Randomized controlled trials were included if patients were clearly monitored, and the incidence of AFF was noted. Ten studies were included in the final analysis. Results: Both amiodarone and sotalol were more effective than placebo treatment in reducing the incidence of postoperative AFF. However, when the data were pooled, no differences were noted between amiodarone and sotalol for efficacy (sotalol, - 21.5%; 95% confidence interval [CI], - 28.3 to - 14.6; amiodarone, - 14.1%; CI, - 20.1 to - 8.1), length of stay (sotalol, - 0.13 d; CI, - 0.33 to 0.07 d; amiodarone, - 0.18; CI, - 0.38 to 0.02 d), or adverse drug reactions causing drug termination (sotalol, 9.7%; CI, 0.086 to 19.3; amiodarone, 1.95%; CI, - 0.48 to 4.38). Conclusions: This data would suggest that either drug could be used in a prophylactic regimen to reduce the incidence of AFF following heart surgery.

UR - http://www.scopus.com/inward/record.url?scp=0036207396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036207396&partnerID=8YFLogxK

U2 - 10.1378/chest.121.4.1203

DO - 10.1378/chest.121.4.1203

M3 - Article

C2 - 11948054

AN - SCOPUS:0036207396

VL - 121

SP - 1203

EP - 1210

JO - Chest

JF - Chest

SN - 0012-3692

IS - 4

ER -